semaglutide boston ma Semaglutide: A Breakthrough in Weight Management Weight Loss Treatments in Boston

Low blood sugar (hypoglycaemia): Particularly if you also take insulin or sulfonylureas

Durability of Results: Maintenance Studies: Tirzepatide (SURMOUNT-3): Continued treatment: Additional 5.5% weight loss Stopped treatment: Regained 14% of weight Conclusion: Need ongoing treatment Semaglutide (STEP-4): Continued treatment: Maintained loss, continued losing Stopped treatment: Regained most weight Conclusion: Need ongoing treatment Phentermine: FDA-approved for 12 weeks only Weight regain after stopping is universal Not a long-term solution All Weight Loss Medications: Obesity is chronic disease Medications treat symptoms, dont cure Stopping medication weight regain Long-term or indefinite use necessary for sustained results Safety Profile Comparison: Discontinuation Due to Side Effects: Tirzepatide: 6.2% Semaglutide: 6.9% Liraglutide: 9.9% Naltrexone-bupropion: 25% (very high) Orlistat: 15-20% Phentermine-topiramate: 8-10% GLP-1s have excellent tolerability considering their effectiveness

To find out more about our weight-loss program, contact one of our three locations at the relevant number below, or use our simple form and follow the directions on-screen to get started

FAQ Does Ozempic show up in a blood test at the plasma center

At En Vogue IV Therapy & Wellness, we ensure you understand what to expect throughout your treatment